Volpara Health Technologies Ltd. (AU:VHT) has released an update.
Shareholders of Volpara Health Technologies, a firm specializing in AI-powered cancer screening software, overwhelmingly approved a buyout scheme by Lunit Inc., with a 96.92% vote in favor. The acquisition is pending final High Court approval and the fulfillment of other conditions, with the expected last trading day for Volpara shares set for May 3, 2024, and scheme consideration payments to shareholders anticipated around May 21, 2024, at AU$1.15 per share.
For further insights into AU:VHT stock, check out TipRanks’ Stock Analysis page.
